NCT07070375View on ClinicalTrials.gov

Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions
Gram-negative Bacterial Infections
Interventions
DRUG

HRS-8427

HRS-8427

Trial Locations (1)

200433

Huashan Hospital Fudan University, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT07070375 - Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function | Biotech Hunter | Biotech Hunter